title: Recurrence of atrial fibrillation after switching from brand to generic atenolol.
abstract: Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.
authors.affiliation: Department of Health Science, University of Catanzaro, Catanzaro, Italy.
authors.forename: Luca
authors.initials: L
authors.lastname: Gallelli
authors.affiliation: Department of Health Science, University of Catanzaro, Catanzaro, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Maida
authors.affiliation: Department of Health Science, University of Catanzaro, Catanzaro, Italy.
authors.forename: Orietta
authors.initials: O
authors.lastname: Staltari
authors.affiliation: Department of Health Science, University of Catanzaro, Catanzaro, Italy.
authors.forename: Pierandrea
authors.initials: P
authors.lastname: Rende
authors.affiliation: Department of Health Science, University of Catanzaro, Catanzaro, Italy.
authors.forename: Emilio
authors.initials: E
authors.lastname: Russo
authors.affiliation: Department of Health Science, University of Catanzaro, Catanzaro, Italy.
authors.forename: Benedetto
authors.initials: B
authors.lastname: Caroleo
authors.affiliation: Department of Health Science, University of Catanzaro, Catanzaro, Italy.
authors.forename: Giovambattista
authors.initials: G
authors.lastname: De Sarro
keywords: Atenolol; atrial fibrillation; brand drug; clinical ineffectiveness; generic drug